Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which blood sugar meter is best? major study puts 5 devices to the test

NCT ID NCT01234727

Knowledge-focused Sponsor: Abbott Diabetes Care Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested five different blood glucose meters in 501 adults with type 1 or type 2 diabetes who use insulin. Participants used multiple devices to see how accurate and reliable each meter is in real-world conditions. The goal was to help people with diabetes and their doctors choose the best monitoring system.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help people with diabetes choose the most accurate and reliable blood glucose meter for their needs.
What could go wrong
This is a completed comparison study, not a treatment trial. Results may not apply to all meters or all people with diabetes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

501 people

The number who actually took part.

Start date

Dec 2010

Finished

Mar 2011

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Up to 480 subjects with type 1 or 2 diabetes mellitus

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subjects diagnosed with type 1 or type 2 diabetes mellitus * Age between 18 and 75 years. * Patients with stable blood glucose in judgment of the investigator. * Subjects receive intensive insulin therapy (Multiple Daily Injection defined as at least two insulin injections per day) * Patients perform blood glucose self measurements on a routine basis * Patients must have experience in self measurement blood glucose for at least 6 months. Exclusion Criteria: * Patients with unstable blood glucose in judgment of the investigator. * Patient has been diagnosed with progressive / serious diseases that in judgment of the investigator preclude successful completion of the observational period. * Lack of compliance or other justifications that, in the discretion of the investigator, precludes satisfactory participation in the study. * Subject without legal capacity. * Blood donation within the last 30 days. * Known pregnancy. * Subject has already participated in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes mellitus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes mellitus

Contacts and locations

Locations

  • Diabetes Zentrum Neuwied

    Neuwied, 56564, Germany

  • Radboud University Nijmegen Centre

    Nijmegen, 6500 HB, Netherlands

  • Zentrum für Diabetes und Gefäßerkrankungen

    Münster, 48145, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.